Randomized phase II study (GATE study) of docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer.
E. Van Cutsem
Disclosure not yet available
C. Boni
Disclosure not yet available
J. Tabernero
Disclosure not yet available
B. Massuti
Disclosure not yet available
D. A. Richards
Disclosure not yet available
H. Prenen
Disclosure not yet available
I. Steinberg
Disclosure not yet available
P. Rougier
Disclosure not yet available